Saudi German Hospital’s H1 profit slips 9% to SAR 162 mln

10/08/2017 Argaam Exclusive

 

Middle East Healthcare Co. (MEAHCO), operator of Saudi German Hospital, reported a net profit of SAR 162.2 million in the first half of 2017, a 9 percent year-on-year (YoY) fall attributed to a 1.9 percent revenue drop, higher caregivers’ salaries and increased cost of financing.



Financials (M)

Item 6m 2016 6m 2017 Change‬
Revenues 831.59 744.81 (10.4 %)
Gross Income 429.10 319.09 (25.6 %)
Operating Income 180.24 166.00 (7.9 %)
Net Income 178.28 171.92 (3.6 %)
Average Shares 92.04 92.04 -
EPS (Riyals) 1.94 1.87 (3.6 %)

The company’s net profit for the second quarter dropped by 23 percent YoY to SAR 57.1 million due to lower revenue, seasonality factors as the holy month of Ramadan and Eid al-Fitr fell in Q2, higher caregivers’ salaries in addition to losses pertaining to the newly-opened Hail Hospital.

 

When compared to the previous quarter, Q2 2017 net profit fell 46 percent, from SAR 105.1 million. 



Current Quarter Comparison (M)

Compared With The
Item Q2 2016 Q2 2017 Change‬
Revenues 410.07 351.28 (14.3 %)
Gross Income 212.49 138.63 (34.8 %)
Operating Income 76.56 58.97 (23.0 %)
Net Income 74.07 61.95 (16.4 %)
Average Shares 92.04 92.04 -
EPS (Riyals) 0.80 0.67 (16.4 %)

View other reports

Share Price

Middle East Healthcare Co.
70.10
(0.50) (0.71 %)

Middle East Healthcare Co. (SAUDI GERMAN HEALTH)

More


Financial Ratios
Current
Market Cap (M Riyal) 6,452.00
Enterprise Value (EV) (M) 8,847.51
Shares Outstanding ((M)) 92.04
EPS ( Riyal) (TTM) 2.30
Book Value (BV) ( Riyal) 18.46
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 33.60
P/E (TTM) 30.53
Price/book 3.80
Return on Average Assets (%) (TTM) 4.2
Return on Average Equity (%) (TTM) 13.2
more


Financial results (Million)

Period Revenues Change Gross Income Change Operating Income Change
Q1 2008 - - - - - -
Q2 2008 - - - - - -
Q3 2008 - - - - - -
Q4 2008 - - - - - -
Q1 2009 - - - - - -
Q2 2009 - - - - - -
Q3 2009 - - - - - -
Q4 2009 - - - - - -
Q1 2010 - - - - - -
Q2 2010 - - - - - -
Q3 2010 - - - - - -
Q4 2010 - - - - - -
Q1 2011 - - - - - -
Q2 2011 - - - - - -
Q3 2011 - - - - - -
Q4 2011 - - - - - -
Q1 2012 - - - - - -
Q2 2012 - - - - - -
Q3 2012 - - - - - -
Q4 2012 - - - - - -
Q1 2013 - - - - - -
Q2 2013 - - - - - -
Q3 2013 - - - - - -
Q4 2013 - - - - - -
Q1 2014 359.18 - 199.49 - 75.11 -
Q2 2014 347.08 - 185.78 - 88.17 -
Q3 2014 323.16 - 174.49 - 71.53 -
Q4 2014 369.34 - 190.01 - 78.37 -
Q1 2015 391.64 9.0 % 208.99 4.8 % 102.89 37.0 %
Q2 2015 372.00 7.2 % 203.88 9.7 % 89.24 1.2 %
Q3 2015 352.20 9.0 % 183.23 5.0 % 88.21 23.3 %
Q4 2015 418.69 13.4 % 214.04 12.6 % 97.86 24.9 %
Q1 2016 421.52 7.6 % 216.62 3.7 % 103.68 0.8 %
Q2 2016 410.07 10.2 % 212.49 4.2 % 76.56 (14.2 %)
Q3 2016 379.09 7.6 % 199.40 8.8 % 91.10 3.3 %
Q4 2016 404.96 (3.3 %) 199.88 (6.6 %) 87.04 (11.1 %)
Q1 2017 393.53 (6.6 %) 180.47 (16.7 %) 107.04 3.2 %
Q2 2017 351.28 (14.3 %) 138.63 (34.8 %) 58.97 (23.0 %)


Profit Performance (Million)

Period Net Income Change EPS(Riyal) Extraordinary Income/Expense Net Profit Before Unusual Items EPS Before XO Items
Q1 2008 - - - - - -
Q2 2008 - - - - - -
Q3 2008 - - - - - -
Q4 2008 - - - - - -
Q1 2009 - - - - - -
Q2 2009 - - - - - -
Q3 2009 - - - - - -
Q4 2009 - - - - - -
Q1 2010 - - - - - -
Q2 2010 - - - - - -
Q3 2010 - - - - - -
Q4 2010 - - - - - -
Q1 2011 - - - - - -
Q2 2011 - - - - - -
Q3 2011 - - - - - -
Q4 2011 - - - - - -
Q1 2012 - - - - - -
Q2 2012 - - - - - -
Q3 2012 - - - - - -
Q4 2012 - - - - - -
Q1 2013 - - - - - -
Q2 2013 - - - - - -
Q3 2013 - - - - - -
Q4 2013 - - - - - -
Q1 2014 80.16 - 0.87 - 80.16 0.87
Q2 2014 92.80 - 1.01 - 92.80 1.01
Q3 2014 74.36 - 0.81 - 74.36 0.81
Q4 2014 84.64 - 0.92 - 84.64 0.92
Q1 2015 105.39 31.5 % 1.15 - 105.39 1.15
Q2 2015 91.79 (1.1 %) 1.00 - 91.79 1.00
Q3 2015 90.75 22.0 % 0.99 - 90.75 0.99
Q4 2015 102.32 20.9 % 1.11 - 102.32 1.11
Q1 2016 104.20 (1.1 %) 1.13 - 104.20 1.13
Q2 2016 74.07 (19.3 %) 0.80 - 74.07 0.80
Q3 2016 99.64 9.8 % 1.08 - 99.64 1.08
Q4 2016 84.73 (17.2 %) 0.92 - 84.73 0.92
Q1 2017 109.97 5.5 % 1.19 - 109.97 1.19
Q2 2017 61.95 (16.4 %) 0.67 - 61.95 0.67

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2008 - - -
Q2 2008 - - -
Q3 2008 - - -
Q4 2008 - - -
Q1 2009 - - -
Q2 2009 - - -
Q3 2009 - - -
Q4 2009 - - -
Q1 2010 - - -
Q2 2010 - - -
Q3 2010 - - -
Q4 2010 - - -
Q1 2011 - - -
Q2 2011 - - -
Q3 2011 - - -
Q4 2011 - - -
Q1 2012 - - -
Q2 2012 - - -
Q3 2012 - - -
Q4 2012 - - -
Q1 2013 - - -
Q2 2013 - - -
Q3 2013 - - -
Q4 2013 - - -
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 53.60 % 25.57 % 23.73 %
Q1 2015 53.05 % 27.10 % 24.96 %
Q2 2015 53.39 % 26.84 % 24.46 %
Q3 2015 52.93 % 27.56 % 25.09 %
Q4 2015 52.79 % 28.05 % 25.43 %
Q1 2016 52.27 % 27.77 % 24.87 %
Q2 2016 51.57 % 26.50 % 23.17 %
Q3 2016 51.71 % 26.41 % 23.34 %
Q4 2016 51.27 % 26.12 % 22.45 %
Q1 2017 49.90 % 26.91 % 23.20 %
Q2 2017 46.99 % 27.02 % 23.30 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2008 - - - -
Q2 2008 - - - -
Q3 2008 - - - -
Q4 2008 - - - -
Q1 2009 - - - -
Q2 2009 - - - -
Q3 2009 - - - -
Q4 2009 - - - -
Q1 2010 - - - -
Q2 2010 - - - -
Q3 2010 - - - -
Q4 2010 - - - -
Q1 2011 - - - -
Q2 2011 - - - -
Q3 2011 - - - -
Q4 2011 - - - -
Q1 2012 - - - -
Q2 2012 - - - -
Q3 2012 - - - -
Q4 2012 - - - -
Q1 2013 - - - -
Q2 2013 - - - -
Q3 2013 - - - -
Q4 2013 - - - -
Q1 2014 92.04 - - 10.70
Q2 2014 92.04 - - 11.69
Q3 2014 92.04 - - 12.48
Q4 2014 92.04 3.61 3.61 12.38
Q1 2015 92.04 3.88 3.88 13.50
Q2 2015 92.04 3.87 3.87 12.67
Q3 2015 92.04 4.05 4.05 13.63
Q4 2015 92.04 4.24 4.24 14.70
Q1 2016 92.04 4.23 4.23 16.39
Q2 2016 92.04 4.03 4.03 15.20
Q3 2016 92.04 4.13 4.13 16.43
Q4 2016 92.04 3.94 3.94 17.32
Q1 2017 92.04 4.00 4.00 18.46
Q2 2017 92.04 3.87 3.87 17.09

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2008 - - -
Q2 2008 - - -
Q3 2008 - - -
Q4 2008 - - -
Q1 2009 - - -
Q2 2009 - - -
Q3 2009 - - -
Q4 2009 - - -
Q1 2010 - - -
Q2 2010 - - -
Q3 2010 - - -
Q4 2010 - - -
Q1 2011 - - -
Q2 2011 - - -
Q3 2011 - - -
Q4 2011 - - -
Q1 2012 - - -
Q2 2012 - - -
Q3 2012 - - -
Q4 2012 - - -
Q1 2013 - - -
Q2 2013 - - -
Q3 2013 - - -
Q4 2013 - - -
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 17.17 17.17 4.43
Q2 2016 17.16 17.16 4.56
Q3 2016 12.41 12.41 3.12
Q4 2016 18.62 18.62 4.23
Q1 2017 18.48 18.48 4.01
Q2 2017 19.45 19.45 4.41

Business Segments (Million)

Compared With The
Period Inpatient clinics Outpatient clinics Pharmacy Sales Others
Q1 2014 207.07 85.01 64.94 2.16
Q2 2014 200.50 77.40 66.66 2.51
Q1 2015 224.99 91.95 70.24 4.46
Q2 2015 211.41 86.64 70.30 3.65
Q3 2015 200.38 85.53 63.54 2.76
Q4 2015 220.47 119.55 72.94 5.72
Q1 2016 241.22 100.20 73.04 7.06
Q2 2016 229.99 99.85 72.93 7.31
Q3 2016 224.32 89.88 62.16 2.72
Q4 2016 220.91 107.73 72.64 3.69
Q1 2017 242.80 104.89 71.94 4.27
Q2 2017 224.48 92.89 70.77 3.54

Analysts Estimates (Million)

Item Q2 2017 (e) Q2 2017 (a) Change‬
Average 85.33 61.95 (27.4 %)

Estimates vs Actual (Million)

Item Q2 2017 (e) Q2 2017 (a) Change
Sico 81.00 61.95 (23.5) %
SNB Capital 86.00 61.95 (28.0) %
Arbah Capital 89.00 61.95 (30.4) %

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Popular Links

Quick Links

Join Us

Argaam.com Copyright © 2024, Argaam Investment, All Rights Reserved
Call Request